Case Control Study
Copyright ©The Author(s) 2023.
World J Psychiatry. Oct 19, 2023; 13(10): 714-723
Published online Oct 19, 2023. doi: 10.5498/wjp.v13.i10.714
Table 1 Baseline data for epilepsy patients with different cognitive function and healthy volunteers
VariableControl (n = 30)Epilepsy
P value
Normal (n = 74)
ECD (n = 37)
P1
P2
Age (yr, mean ± SD)33.93 ± 9.3935.27 ± 9.7334.68 ± 9.500.5230.760
Gender, n (%)
Male1748 (64.86)20 (54.05)0.4340.270
Female1326 (35.14)17 (45.95)
Education level, n (%)
Junior/senior high school1946 (62.16)20 (54.05)0.9110.412
University or above1128 (27.84)17 (45.95)
Epilepsy onset age (yr, mean ± SD)26.15 ± 7.4125.62 ± 10.520.760
Epilepsy duration (yr, mean ± SD)9.12 ± 5.609.05 ± 4.100.948
Epilepsy type, n (%)
Focal20 (27.03)9 (24.32)0.760
Overall54 (72.97)28 (75.68)
Types of epilepsy drugs, n (%)
0–157 (77.03)26 (70.27)0.440
2–317 (22.97)11 (29.73)
Epilepsy treatment protocol, n (%)
VPN39 (52.70)19 (51.35)0.890
No-VPN35 (47.30)18 (48.65)